We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+16.73%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$7.31B
AUM Growth
+$1.27B
Cap. Flow
+$483M
Cap. Flow %
6.6%
Top 10 Hldgs %
32.03%
Holding
355
New
109
Increased
77
Reduced
150
Closed
13

Top Buys

Rank Stock Value
1
DDOG icon
Datadog
DDOG
+$69.4M
2
RBLX icon
Roblox
RBLX
+$67M
3
ADBE icon
Adobe
ADBE
+$48.4M
4
ANET icon
Arista Networks
ANET
+$47.4M
5
EPAM icon
EPAM Systems
EPAM
+$29M

Top Sells

Rank Stock Value
1
RGEN icon
Repligen
RGEN
+$30M
2
MBLY icon
Mobileye
MBLY
+$26.6M
3
CALX icon
Calix
CALX
+$15.7M
4
HUBS icon
HubSpot
HUBS
+$15.7M
5
DEN
Denbury Inc.
DEN
+$15.7M

Sector Composition

Rank Sector Weight
1 Technology 32.88%
2 Consumer Discretionary 19.89%
3 Healthcare 16.44%
4 Communication Services 10%
5 Industrials 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYBR
201
DELISTED
CyberArk
CYBR
$1.37M 0.02%
8,794
– –
SG icon
202
Sweetgreen
SG
$813M
$1.31M 0.02%
102,342
+839
+0.8% +$7.76K
VEEV icon
203
Veeva Systems
VEEV
$43.2B
$1.31M 0.02%
6,612
-41
-0.6% -$7.48K
COIN icon
204
Coinbase
COIN
$45.4B
$1.19M 0.02%
+16,652
New +$993K
SIBN icon
205
SI-BONE Inc
SIBN
$831M
$1.11M 0.02%
41,065
-244
-0.6% -$5.95K
UBER icon
206
Uber
UBER
$146B
$1.1M 0.02%
25,444
+111
+0.4% +$4.13K
VYGR icon
207
Voyager Therapeutics
VYGR
$190M
$1.08M 0.01%
94,551
-2,226
-2% -$23K
ARLO icon
208
Arlo Technologies
ARLO
$1.45B
$1.03M 0.01%
94,570
-82,907
-47% -$674K
ANF icon
209
Abercrombie & Fitch
ANF
$5.74B
$996K 0.01%
+26,422
New +$753K
SONO icon
210
Sonos
SONO
$1.85B
$914K 0.01%
55,996
-484
-0.9% -$8.58K
KRYS icon
211
Krystal Biotech
KRYS
$9.97B
$881K 0.01%
7,503
+1,876
+33% +$192K
CYTK icon
212
Cytokinetics
CYTK
$9.64B
$863K 0.01%
26,464
-373
-1% -$13.8K
PCVX icon
213
Vaxcyte
PCVX
$8.81B
$850K 0.01%
17,022
+3,454
+25% +$164K
CLFD icon
214
Clearfield
CLFD
$397M
$831K 0.01%
17,547
+62
+0.4% +$2.65K
COHR icon
215
Coherent
COHR
$53.1B
$803K 0.01%
15,760
-20
-0.1% -$742
CHWY icon
216
Chewy
CHWY
$8.52B
$782K 0.01%
19,811
-499
-2% -$17.4K
MLTX icon
217
MoonLake Immunotherapeutics
MLTX
$1.04B
$767K 0.01%
+15,047
New +$405K
WDAY icon
218
Workday
WDAY
$46B
$739K 0.01%
3,271
-98
-3% -$19.6K
RELY icon
219
Remitly
RELY
$4.62B
$716K 0.01%
38,051
+20,193
+113% +$367K
BHVN icon
220
Biohaven
BHVN
$1.86B
$612K 0.01%
+25,595
New +$441K
BBIO icon
221
BridgeBio Pharma
BBIO
$13.4B
$612K 0.01%
35,556
+3,716
+12% +$55.9K
SLRN
222
DELISTED
ACELYRIN
SLRN
$595K 0.01%
+28,483
New +$583K
STOK icon
223
Stoke Therapeutics
STOK
$1.82B
$543K 0.01%
51,074
-863
-2% -$9.18K
SNAP icon
224
Snap
SNAP
$9.86B
$519K 0.01%
43,872
-321,929
-88% -$3.23M
PATH icon
225
UiPath
PATH
$7.42B
$511K 0.01%
30,853
+146
+0.5% +$2.34K
7 8
9
10 11

Similar funds

Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
SC
Starlite Capital Dallas, Texas $9.7B AUM
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.8B AUM 0.07% 1-Year Est. Return
HTC
Hershey Trust Company Hershey, Pennsylvania $9.82B AUM 0.48% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Gilder Gagnon Howe & Co held 355 positions worth $7.31B, up 21% from $6.04B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Gilder Gagnon Howe & Co deployed $483M of net new capital in Q2 2023, opening 109 new positions and adding to 77 existing holdings. Its largest new stake was Intel: 532,525 shares worth $17.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Repligen, an estimated $30M trimmed.

  • Gilder Gagnon Howe & Co's largest Q2 2023 buy was Intel: 532,525 shares worth $17.8M.
  • Gilder Gagnon Howe & Co added most to Datadog in Q2 2023, an estimated $69.4M increase.
  • Gilder Gagnon Howe & Co's biggest Q2 2023 reduction was Repligen, cutting an estimated $30M.
  • Gilder Gagnon Howe & Co fully exited Apollo Endosurgery, Inc. in Q2 2023, selling an estimated $3.69M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 32% of its $7.31B portfolio in Q2 2023.
  • Gilder Gagnon Howe & Co opened 109 new positions and closed 13 in Q2 2023.
  • Gilder Gagnon Howe & Co's portfolio value rose 21% quarter-over-quarter to $7.31B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2023, filed 14 Aug 2023.